PRINCETON, N.J., March 25, 2011 /PRNewswire/ -- CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks.
"The legacy of our organization has been the proactive insight and collaborative input our physicians, scientists and operational personnel have provided to the many industry associations, professional healthcare organizations and regulatory agencies around the world over the past decade," said CoreLab Partners' Vice President of Global Business Development, Kevin Duffy. "Many of our on-staff board-certified radiologists, oncologists and cardiologists are recognized thought leaders in their respective fields and continue to serve on many of the industry-shaping advisory and steering committees in the drug development market sector. This unwavering medical and scientific commitment is a hallmark of CoreLab Partners expertise and signals a corporate culture which is reflected in our new company tag line for 2011: 'Driven by Science,'" added Duffy.
CoreLab Partners invites you to learn more about their full line of cardiac safety and imaging science capabilities at these important industry events:
28-30 March 2011
23rd Annual DIA Euro Meeting
Exhibiting: Booth # 1230
DIA Euro Meeting
28-31 March 2011
Drug Discovery World Asia/Drug Safety World Asia 2011
Marina Bay Sands, Singapore
Exhibiting: booth # A05
Dr. Boaz Mendzelevski, VP, Cardiology, presenting, "Regulatory trends in designing and analyzing QT studies to ensure drug safety"
Tuesday, 29th March, 14:00
Drug Safety World Asia
30 March-1 April
20th Annual Partnerships in Clinical Trials USA
Exhibiting: Booth # 921
2-6 April 2011
AACR 2011 Annual Meeting
Exhibiting: Booth # 2370
About CoreLab Partners, Inc
CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry and Pulse Wave Analysis.
Kevin D. Duffy
Vice President, Global Business Development
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
SOURCE CoreLab Partners, Inc